FindTrial
Sign In

Study for the prevention of nikethamide on respiratory dyspnea for propofol combined sufentanil in painless endoscopy

Study for the prevention of nikethamide on respiratory dyspnea for propofol combined sufentanil in painless endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027816
Enrollment
Unknown
Registered
2019-11-29
Start date
2019-11-30
Completion date
Unknown
Last updated
2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

respiratory disease

Interventions

Group 2:nikethamide 0.375mg iv
Group 1:propofol combined sufentanil

Sponsors

Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. aged 18-65 years old; 2. planned to receive painless endoscopy under propofol combined with sufentanil; 3. Signed informed consent.

Exclusion criteria

Exclusion criteria: cardiovascular disease,hypertension,respiratory disease, difficult airway, allergery to propofol and sufentanil,abnormal function of liver and kidney

Design outcomes

Primary

MeasureTime frame
mean blood pressure;heart rate;SpO2;respiratory dyspnea;respiratory treatment;dose of propofol;dose of sufentanil;time of examination;—

Countries

China

Contacts

Public ContactZhengfeng Gu

Wuxi People's Hospital

gzf110677@163.com+86 13861789062

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026